Randomized Trial of Ibudilast for Methamphetamine Dependence

Trial Profile

Randomized Trial of Ibudilast for Methamphetamine Dependence

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2018

At a glance

  • Drugs Ibudilast (Primary)
  • Indications Drug abuse
  • Focus Therapeutic Use
  • Acronyms IBUD phII
  • Most Recent Events

    • 29 Mar 2018 Results presented in the MediciNova media release.
    • 29 Mar 2018 Primary endpoint Methamphetamine use has not been met, according to the MediciNova media release.
    • 29 Mar 2018 Status changed from active, no longer recruiting to completed, according to the MediciNova media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top